Combining YAP1 depletion with anti-PD-1 immune checkpoint blockade produced synergistic effects, further suppressing tumor growth, increasing CD8+; T-cell infiltration, and decreasing markers of T-cell exhaustion. Here, CD8A is linked to neoplasm.